Ozone Therapy for Women With Endometriosis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age25-45
SponsorUniversidade Federal do Paraná

About this trial

To evaluate the action of ozone therapy as an adjuvant treatment in patients with endometriosis. Secondary Objective: To evaluate the efficacy of ozone therapy for pelvic analgesia in women with endometriosis; To compare the imaging diagnostic techniques of transvaginal ultrasound with infrared thermography in the pre-treatment (before), fourth, seventh and post-treatment (10th session) periods; To evaluate the application of the consolidated questionnaire (EHP-30) in the changes in the quality of life of the participants immediately after the intervention.

Eligibility criteria

Qualifiers

Women with a clinical diagnosis of endometriosis (ultrasonography / transvaginal exam)

25-45 years old

Disqualifiers

Pregnancy

G6PD positive

Addicted

HIV and hepatitis positive

Trial design

Treatments tested in this trial

  • Ozone therapy

Treatment groups

40 Participants
are divided into 1 treatment group

Sponsors and collaborators

Universidade Federal do Paraná

Lead sponsor

Philozon Geradores de Ozonio LTDA

Collaborator